Advertisement

Photodynamic Therapy

  • Maria Claudia Almeida IssaEmail author
  • Diego Cerqueira Alexandre
Reference work entry
Part of the Clinical Approaches and Procedures in Cosmetic Dermatology book series (CAPCD, volume 1)

Abstract

Photodynamic therapy (PDT) consists of a chemical reaction activated by light source that is used in the management of many skin diseases. The most extensively studied photosensitizing agents for PDT are 5-aminolevulinic and methyl aminolevulinate (MAL). The light sources used in photodynamic therapy should emit light at optimal wavelengths to excite the photosensitizer and produce reactive oxygen species. PDT should be considered as a therapeutic option, particularly in the case of non-melanoma skin cancer such as actinic keratosis, basal cell carcinoma, and Bowen disease. It can also be used in some inflammatory and infectious disease. Photorejuvenation is a new spectrum of PDT use, which is being widely studied. Daylight-mediated PDT is a new modality of PDT, which was developed to minimize patient discomfort, maintaining PDT efficacy. This chapter will approach its concept, mechanism of action, procedure, and indications.

Keywords

Photodynamic therapy Non-melanoma skin cancer Photosensitizer Light source Skin rejuvenation Acne Daylight-mediated photodynamic therapy 

References

  1. Braathen LR, Paredes BE, Saksela O, Fritsch C, Gardlo K, Morken T, et al. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses. J Eur Acad Dermatol Venereol. 2008;23:550–5. doi:10.1111/j.1468-3083.2008.03029.x.CrossRefGoogle Scholar
  2. Chaves YN, Torezan LA, Niwa ABM, Sanches JA, Festa Neto C. Pain in photodynamic therapy: mechanism of action and management strategies. An Bras Dermatol. 2012;87(4):521–9.CrossRefPubMedGoogle Scholar
  3. Christensen E, Warloe T, Kroon S, Funk J, Helsing P, Soler AM, et al. Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. J Eur Acad Dermatol Venereol. 2010;24:505–12. doi:10.1111/j.1468-3083.2009.03430.x.CrossRefPubMedGoogle Scholar
  4. Fernández-Guarino M, Jaén-Olasolo P. Terapia fotodinámica en micosis fungoides. Actas Dermosifiliogr. 2013:1–7. doi:10.1016/j.ad.2012.11.004.Google Scholar
  5. Foley P. Clinical efficacy of methyl aminolaevulinate photodynamic therapy in basal cell carcinoma and solar keratosis. Australas J Dermatol. 2005;46:S8–10.CrossRefPubMedGoogle Scholar
  6. Fontanelli R, Papadia A, Martinelli F, Lorusso D, Grijuela B, Merola M, et al. Photodynamic therapy with M-ALA as non surgical treatment option in patients with primary extramammary Paget’s disease. Gynecol Oncol. 2013:1–5. doi:10.1016/j.ygyno.2013.04.008.Google Scholar
  7. Gong Y, Labh S, Jin Y, Diao HY, XL L, Liu ZY, et al. Needle-free injection of 5-aminolevulinic acid in photodynamic therapy for the treatment of non-melanoma skin cancer. Dermatol Ther. 2016;29:255–62.CrossRefPubMedGoogle Scholar
  8. Issa MCA, Piñeiro-Maceira J, Farias RE, Pureza M, Luiz R, Manela-Azulay M. Immunohistochemical expression of matrix metalloproteinases in photodamaged skin by photodynamic therapy. Br J Dermatol. 2009;161:647–53. doi:10.1111/j.1365-2133.2009.09326.x.CrossRefGoogle Scholar
  9. Issa MCA, Piñeiro-Maceira J, Vieira MTC, Olej B, Mandarim-de-Lacerda CA, Luiz RR, et al. Photorejuvenation with topical methyl aminolevulinate and red light: a randomized, prospective, clinical, histopathologic, and morphometric study. Dermatol Surg. 2010;36:39–48. doi:10.1111/j.1524.4725.2009.01385.x.CrossRefPubMedGoogle Scholar
  10. Issa et al. Transepidermal drug delivery in daylight photodynamic therapy in the treatment of photodamaged skin: a pilot study. Surg Cosmet Dermatol 2016;8(4 Supl. 1): S23-33. doi: http://dx.doi.org/10.5935/scd1984-8773.201683104.Google Scholar
  11. Keyal U, Bhatta AK, Wang XL. Photodynamic therapy for treatment of different severity of acne: a systematic review. Photodiag Photodyn Ther. 2016;14:191–9.CrossRefGoogle Scholar
  12. Lv W, Zhang Z, Zhang KY, Yang H, Liu S, Xu A, et al. A mitochondria-targeted photosensitizer showing improved photodynamic therapy effects under hypoxia. Angew Chem Int Ed. 2016;55:9947–51. doi:10.1002/anie.2016604130.CrossRefGoogle Scholar
  13. Morton CA. Topical photodynamic therapy for Bowen’s disease. Australas J Dermatol. 2005;46:S11.CrossRefPubMedGoogle Scholar
  14. Neves DR, Ramos DG, Magalhães GM, Rodrigues RC, Souza JBA. Terapia fotodinâmica para tratamento de múltiplas lesões no couro cabeludo na síndrome do nevobasocelular – relato de caso. An Bras Dermatol. 2016;85(4):545–8.CrossRefGoogle Scholar
  15. Osiecka BJ, Jurczyszyn K, Ziółkowski P. The application of Levulan-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma. Med Sci Monit. 2012;18(2):PI5–9.CrossRefPubMedGoogle Scholar
  16. Ozog DM, Rkein AM, Fabi SG, Gold MH, Goldman MP, Lowe NJ, et al. Photodynamic therapy: a clinical consensus guide. Dermatol Surg. 2016;42:804–27. doi:10.1097/dss.0000000000000800.CrossRefPubMedGoogle Scholar
  17. Pauwels C, Hautier-Mazereeuw J, Basset-Seguin N, Livideanu C, Viraben R, Paul C, et al. Topical methyl aminolevulinate photodynamic therapy for management of basal cell carcinomas in patients with basal cell Nevis syndrome improves patient’s satisfaction and reduces the need for surgical procedures. J Eur Acad Dermatol Venereol. 2011;25:861–4. doi:10.1111/j.1468-3083.2010.03854.x.CrossRefPubMedGoogle Scholar
  18. Sunar U, Rohrbach DJ, Morgan J, Zeitouni N, Handerson BW. Quantification of PpIX concentration in basal cell carcinoma and squamous cell carcinoma models using spatial frequency domain imaging. Biomed Opt Express. 2013;4(4):531–7.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Szeimeis RM. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma. Dermatol Clin. 2007;25:89–94.CrossRefGoogle Scholar
  20. Torezan L, Niwa ABM, Festa Neto C. Terapia fotodinâmica em dermatologia: princípios básicos e aplicações. An Bras Dermatol. 2009;84(5):445–59.CrossRefPubMedGoogle Scholar
  21. Wang Y, Yang Y, Yang Y, Lu Y. Surgery combined with topical photodynamic therapy for the treatment of squamous cell carcinoma of the lip. Photodiag Photodyn Ther. 2016;14:170–2.CrossRefGoogle Scholar
  22. Wiegell SR, Fabricius S, Gniadecka M, Stender IM, Berne B, Kroon S, et al. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicenter study. Br J Dermatol. 2012;166:1327–32. doi:10.1111/j.1365-2133.2012.10833.x.CrossRefPubMedGoogle Scholar
  23. Wlodeck C, Ali FR, Lear JT. Use of photodynamic therapy for treatment of actinic keratosis in organ transplant recipients. Biomed Res Int. 2012;2013:1–7.CrossRefGoogle Scholar
  24. Zane C, Fabiano A, Arisi M, Calzavara-Pinton P. A randomized split-face clinical trial of photodynamic therapy with methyl aminolevulinate versus ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and scalp. Dermatology. 2016;232:472–7. doi:10.1159/000447355.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Maria Claudia Almeida Issa
    • 1
    Email author
  • Diego Cerqueira Alexandre
    • 2
  1. 1.Department of Clinical Medicine – DermatologyFluminense Federal UniversityNiteróiBrazil
  2. 2.Universidade Federal FluminenseNiteróiBrazil

Personalised recommendations